STAT3 and neoplasm: In vitro and in vivo experiments showed that the biomimetic nanodrugs accurately targeted tumor tissues, effectively downregulate the expression of STAT3, and synergistically induce tumor ICD through a synergistic chemo‐gene therapeutic approach, thus remodeling the immunosuppressive tumor TME and remarkably inhibiting the growth of primary tumors and distant metastases.[101]